Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 508 participants.

Also called NCT02646397

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 508 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02646397
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02646397. Randomized; no masking; primary purpose treatment. Start 2016-02 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
Acronym
BEAHIT
Intervention (Drug)
Fosinopril
Intervention (Drug)
Benidipine
Intervention (Drug)
Hydrochlorothiazide
Lead sponsor
Shanghai Changzheng Hospital (class: other)
Collaborator
First Affiliated Hospital of Zhejiang University (class: other)
Collaborator
Zhongda Hospital (class: other)
Collaborator
Ruijin Hospital (class: other)
Collaborator
The First Affiliated Hospital of Zhengzhou University (class: other)
Collaborator
Sichuan Provincial People's Hospital (class: other)
Collaborator
The Second Affiliated Hospital of Dalian Medical University (class: other)
Collaborator
The First Affiliated Hospital of Anhui Medical University (class: other)

Record details

Record id
cardio:ct-nct02646397
Content hash
f7f170c1ad58f07a237921ae2764c824051b1594dcd096cd59deaa4649c7d1dc